oa De Rebus - Biotech inventions - the impact in South Africa of recent case law in other jurisdictions : practice note - intellectual property law
The decision of the United States (US) Supreme Court in Association for Molecular Pathology, et al. v Myriad Genetics, Inc., et al 569 U.S. 133 S.Ct. 2107 (2013) (the US Myriad case) was a landmark case on the patentability of biotechnological inventions. In particular the US Myriad case dealt with the issue of patentability of naturally occurring genes or nucleotide sequences, which have been isolated and characterised.
Article metrics loading...